drugset / Trial / NCT01880931

The Effect Site Concentration of Remifentanil for Preventing QTc Interval Prolongation During Intubation in Normotensive and Hypertensive Patients

NCT01880931

Completed 44 enrolled Severance Hospital
Non-randomizedParallel-groupDouble-blindPrevention

Summary

To find out the effect site concentration of remifentanil for preventing QTc interval prolongation during intubation under propofol-remifentanil anesthesia in normotensive and hypertensive patients

Timeline

Start
2013-06
Primary completion
2014-11
Completion
2014-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule

Indications

No indication recorded.